This study will examine whether gum/periodontal diseases prior to cancer therapy impacts cancer therapy side-effects, quality of life, and response to treatment.
Lung CA Dental
Evaluating periodontal health in subjects with lung cancer prior to cancer therapy and monitoring impact of periodontal disease on treatment efficacy and side-effects.
Non-small cell lung cancer
All genders
45+
Recruiting now
Overview
Principal Investigator: Dominique Michaud
Contact Us
Latoya Marshall
Study details
Inclusion Criteria
- Male and female patient aged 45 years or older (as periodontal disease is more common in older individuals)
- Patients must sign an informed consent before data collection
- Patients who are scheduled to undergo radiation and/or chemotherapy and/or immunotherapy for stages III and IV non-small cell lung cancer (NSCLC)
Exclusion Criteria
- Patients who have already received cancer therapy other than surgery
- Patients with a prior history of cancer (other than non-melanoma skin cancer) or stage I-II lung cancer
- Non-English speaking patients
Study Requirements
The study will be conducted over a 6-month period. Patients who agreed to participate will be asked to complete two questionnaires before their treatment starts (baseline characteristics/behaviors, and Qualty of Life (QoL) questionnaires) and the QoL questionnaire will be given a second time after completion of first round of therapy (~4 weeks later). The questionnaires will be offered in REDCap as an online questionnaire to be completed on an iPad provided to patients.
The study team will review the patient medical records and abstract the information needed for this study related to the patient lung cancer disease and treatment over 6 months. Dental records related to the patients’ periodontal disease conditions, including X-rays will also be collected by the study team.